IQVIA (IQV) is a publicly traded Healthcare sector company. As of May 20, 2026, IQV trades at $169.28 with a market cap of $28.84B and a P/E ratio of 20.97. IQV moved -0.93% today. Year to date, IQV is -26.89%; over the trailing twelve months it is +18.32%. Its 52-week range spans $134.65 to $247.05. Analyst consensus is strong buy with an average price target of $215.90. Rallies surfaces IQV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IQVIA jumps as Q1 beats expectations and full-year EPS guidance rises: IQVIA shares are higher after the company reported Q1 2026 results that beat expectations and lifted its full-year adjusted EPS outlook. Investors also cheered strong cash generation and continued share repurchases alongside reaffirmed full-year revenue guidance.
| Metric | Value |
|---|---|
| Price | $169.28 |
| Market Cap | $28.84B |
| P/E Ratio | 20.97 |
| EPS | $8.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.05 |
| 52-Week Low | $134.65 |
| Volume | 1.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $16.63B |
| Net Income | $1.39B |
| Gross Margin | 0.00% |
12 analysts cover IQV: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $215.90.